Boehringer Ingelheim Corporation Release: Major European Regulatory Milestone in Cardiovascular Protection for MICARDIS(R) (telmisartan): Now Approved by the European Commission (EC) to Reduce the Risk of Cardiovascular (CV) Morbidity in High CV Risk Pati